JAGUAR HEALTH, INC. (JAGX) ROI
- 2018-06-30: ROI -116.20%.
- 2018-03-31: ROI -71.98%.
- 2017-12-31: ROI -73.59%.
- 2017-06-30: ROI 405.26%.
Complete source-backed roi history.
- Available history
- 2015-09-30 to 2018-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2018-06-30 | -116.20% |
| 2018-03-31 | -71.98% |
| 2017-12-31 | -73.59% |
| 2017-06-30 | 405.26% |
| 2017-03-31 | 539.93% |
| 2016-12-31 | -1148.37% |
| 2016-09-30 | -395.09% |
| 2016-06-30 | -257.73% |
| 2016-03-31 | -157.14% |
| 2015-12-31 | -159.69% |
| 2015-09-30 | -98.96% |
Annual ROI
| Date | ROI |
|---|---|
| 2016-12-31 | -1148.37% |
| 2015-12-31 | -159.69% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |